How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Virtual Neurorehabilitation Device Market
- By Device Type: Wearable Neurorehabilitation Devices, Stationary Neurorehabilitation Systems, Robotic Neurorehabilitation Devices, Virtual Reality Headsets for Neurorehabilitation, Sensor-based Neurorehabilitation Devices
- By Therapy Type: Motor Function Rehabilitation, Cognitive Rehabilitation, Speech and Language Therapy, Balance and Coordination Training, Sensory Rehabilitation
- By End User: Hospitals and Clinics, Rehabilitation Centers, Home Care Settings, Research and Academic Institutions, Outpatient Therapy Centers
- By Neurological Disorder: Stroke Rehabilitation, Traumatic Brain Injury Rehabilitation, Spinal Cord Injury Rehabilitation, Multiple Sclerosis Rehabilitation, Parkinson’s Disease Rehabilitation
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wearable Neurorehabilitation Devices leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Virtual Neurorehabilitation Device Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
Therapy Type 5
End User 5
Neurological Disorder 5
Companies profiled
Hocoma AG
Tyromotion GmbH
Bionik Laboratories Corp.
Reha Technology Ltd.
Motek Medical
MindMaze
Neofect
Aretech LLC
Virtualware Group
MediTouch
Penumbra Inc.
Cyberdyne Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Hocoma AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Tyromotion GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bionik Laboratories Corp.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Reha Technology Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Motek Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →MindMaze
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Neofect
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Aretech LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Virtualware Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →MediTouch
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Penumbra Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Cyberdyne Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Ekso Bionics Holdings Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →AlterG Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →ReWalk Robotics Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,861M by 2033 · 7.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wearable Neurorehabilitation Devices51.6
- Stationary Neurorehabilitation Systems12.0
- Robotic Neurorehabilitation Devices9.1
- Virtual Reality Headsets for Neurorehabilitation15.1
- Sensor-based Neurorehabilitation Devices12.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,289M → $2,197M · 6.9%
Europe$898.1M → $1,759M · 8.8%
Asia Pacific$820.0M → $1,525M · 8.1%
Latin America$507.6M → $942.6M · 8.0%
Middle East and Africa$390.5M → $633.1M · 6.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.252026
7.272027
7.282028
7.282029
7.312030
7.312031
7.322032
7.352033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Hocoma AG17.7
- Tyromotion GmbH9.3
- Bionik Laboratories Corp.10.0
- Reha Technology Ltd.8.1
- Motek Medical14.2
- MindMaze12.8
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type33.8%
Therapy Type22.7%
End User14.9%
Neurological Disorder28.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.1
- Europe24.9
- Asia Pacific21.6
- Latin America13.4
- Middle East and Africa9.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Hocoma AG | 88 | 93 | 77 | 81 | 98 | 73 | 85 |
| Tyromotion GmbH | 82 | 87 | 82 | 92 | 74 | 92 | 85 |
| Bionik Laboratories Corp. | 73 | 67 | 72 | 87 | 77 | 78 | 76 |
| Reha Technology Ltd. | 80 | 67 | 57 | 71 | 77 | 70 | 70 |
| Motek Medical | 75 | 58 | 63 | 57 | 65 | 71 | 65 |
| MindMaze | 54 | 59 | 66 | 71 | 67 | 46 | 61 |
| Neofect | 52 | 57 | 55 | 47 | 58 | 52 | 54 |
| Aretech LLC | 45 | 38 | 47 | 47 | 53 | 44 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Hocoma AG
- Tyromotion GmbH
- Bionik Laboratories Corp.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Hocoma AG | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Tyromotion GmbH | ✓ | ◐ | ✓ | ◐ | − | ✓ |
| Bionik Laboratories Corp. | ✓ | ✓ | − | ✓ | ◐ | ✓ |
| Reha Technology Ltd. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Motek Medical | ✓ | ◐ | ◐ | − | − | ◐ |
| MindMaze | ◐ | ◐ | ✓ | ◐ | − | − |
| Neofect | − | ◐ | ◐ | ◐ | ◐ | − |
| Aretech LLC | − | ◐ | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Hocoma AG85
2Tyromotion GmbH85
3Bionik Laboratories Corp.76
4Reha Technology Ltd.70
5Motek Medical65
6MindMaze61
7Neofect54
8Aretech LLC46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Hocoma AGTyromotion GmbH
Challenger2
Strong scale, closing on the leaders.
Bionik Laboratories Corp.Reha Technology Ltd.
Contender2
Focused players with pockets of strength.
Motek MedicalMindMaze
Niche2
Specialists in a single segment or region.
NeofectAretech LLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Virtual Neurorehabilitation Device Market — a $927M beachhead inside a $12.2B market.
Beachhead (SOM)$927Mobtainable near-term
Serviceable (SAM)$5.06Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Wearable Neurorehabilitation Devices
Best fit — highest urgency & budget in Device Type.
Economic buyer75 fit
Stationary Neurorehabilitation Systems
Strong fit — clear ROI and a fast path to value.
End user66 fit
Robotic Neurorehabilitation Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Therapy Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve18%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Virtual Neurorehabilitation Device Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified24%
Evaluation14%
Closed-won6%
$11.5KCAC
$65KLTV
5.6:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Virtual Neurorehabilitation Device Market is a durable-growth opportunity — $8.08B by 2033, compounding at 6.3%.
TAM · 2025$4.98Btoday
TAM · 2033$8.08Bforecast
CAGR6.3%2027–2033
Cumulative$57.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.08BTotal addressable market
SAM$3.14BServiceable available market
SOM$591MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.3% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.08BLarge & growingTAM by 2033 at 6.3% CAGR
$3.14BServiceable nowreachable with today’s model
$591MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.31BBear4.1% CAGR
$8.08BBase6.3% CAGR
$10.3BBull8.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Therapy Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Virtual Neurorehabilitation Device Market — a $12.4B market by 2033. Plan: grow share from 5.3% to 11.6%.
Market size · 2033$12.4Btotal addressable
Market CAGR10.6%2027–2033
Target share11.6%from 5.3% today
Revenue ambition$1.43Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.3% | 11.6% | At risk |
| Revenue | $651M | $1.43B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 37.4% | 45.1% | On track |
| Customer retention | 85.9% | 95.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Therapy Type capability
A defensible second engine — invest in Therapy Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Therapy Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $194M capacity & capability investment
- Greenlight bolt-on M&A in Therapy Type
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Virtual Neurorehabilitation Device Market conversation — a $7.95B market you can size, segment and defend in minutes.
Market size · 2033$7.95Btotal opportunity
Growth9.8%CAGR to 2033
Addressable buyers1,730+accounts in scope
Typical ROI4.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.9×return on cost, year one
< 2 mopayback period
$96K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Hocoma AGTyromotion GmbHBionik Laboratories Corp.Reha Technology Ltd.Motek MedicalMindMazeNeofectAretech LLC+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Virtual Neurorehabilitation Device Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Virtual Neurorehabilitation Device Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Virtual Mother and Child Healthcare Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportVirtual Microscopy Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportVirtual Medical Diagnostics Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportVirtual Medical Assistant Service Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportVirtual Human Anatomy Software Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportVirtual Hospital Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportVirtual Healthcare Delivery Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportVirtual Fitness Software Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportVirtual Fitness Platform for The Disabled Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportVirtual-First Care Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportVirtual Drug Screening System Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportVirtual Drug Discovery Service Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.